RxDoctor Payments Data

Samantha Volstorf

Family · Paris, ILNPI 1285748814

Payments from drug & device makers

$5,016in general payments, 2019–2025

Across 64 payments — averaging $78.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Janssen Global Services, LLC$4K
  • Ironshore Pharmaceuticals Inc.$147
  • Otsuka America Pharmaceutical, Inc.$140
  • Novartis$111
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$70
  • Almatica Pharma LLC$67
  • plus $492 from 15 others

What the payments were for

  • Consulting fees$3,19064%
  • Travel & lodging$48710%
  • Food & beverage$1,29326%
  • Education$471%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,016 in reported general payments places this provider in the 90th percentile of 4,941 family providers in Illinois.

See all family providers in Illinois

Most prescribed under Part D

DrugClaimsCost to plans & patients
Abilify MaintenaAripiprazole11$32,972
Trelegy ElliptaFluticasone/Umeclidin/Vilanter31$19,140
TrulicityDulaglutide15$15,318
OzempicSemaglutide12$11,521
JanuviaSitagliptin Phosphate14$10,238
LinzessLinaclotide16$8,902
CorlanorIvabradine Hcl11$6,398
Tiotropium Bromide12$5,023
Vilazodone Hcl21$2,872
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl22$2,801
Bupropion XlBupropion Hcl100$2,730
SymbicortBudesonide/Formoterol Fumarate11$2,448
Pregabalin22$1,904
Desvenlafaxine Succinate ErDesvenlafaxine Succinate30$1,883
BreynaBudesonide/Formoterol Fumarate12$1,870

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Otsuka America Pharmaceutical, Inc.Abilify Maintena$140$32,97211 claims
Lilly USA, LLCTrulicity$20$15,31815 claims
Novo NordiskOzempic$43$11,52112 claims
MerckJanuvia$12$10,23814 claims
AbbVieLinzess, Synthroid$59$9,82737 claims
AmgenCorlanor$41$6,39811 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,941 family providers in Illinois.

Other family in Paris

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →